Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.11.10
Jefferies Maintains Buy on Hut 8, Lowers Price Target to $81
Benzinga
2026.11.10
Stran & Co Q3 EPS $0.00 Up From $(0.07) YoY, Sales $28.100M Up From $25.981M YoY
Benzinga
2026.11.10
Astronics Sees Q4 Sales $255.000M-$275.000M vs $274.570M Est
Benzinga
2026.11.10
Astronics Affirms FY2026 Sales Guidance of $1.020B-$1.040B vs $1.018B Est
Benzinga
2026.11.10
Autolus Therapeutics Presents Longer-Term Follow Up Data From Ongoing CARLYSLE Phase 1 Trial; Data Show Clinically Significant Improvements In SLEDAI-2K Scores And Achievement Of DORIS In Most Patients Despite Severe Disease Activity At Baseline
Benzinga
2026.11.10
Gossamer Bio Q3 EPS $(7.36) Misses $(3.68) Estimate, Sales $38.431M Beat $12.148M Estimate
Benzinga
2026.11.10
Silicon Laboratories Q3 Adj. EPS $1.05 Beats $0.84 Estimate, Sales $250.892M Beat $242.096M Estimate
Benzinga
2026.11.10
Spectral AI Q3 EPS $(0.11) Beats $(0.14) Estimate, Sales $2.856M Miss $5.325M Estimate
Benzinga
2026.11.10
Factorial Energy Q3 Sales $26.000K
Benzinga
2026.11.10
NanoXplore Sees Q2 Sales $31.000M-$32.000M vs $33.298M Est
Benzinga
2026.11.10
American Integrity Q3 Adj. EPS $1.44 Beats $0.67 Estimate, Sales $113.492M Beat $100.419M Estimate
Benzinga
2026.11.10
Stubhub Holdings Q3 EPS $0.05 Misses $0.11 Estimate, Sales $501.953M Miss $513.878M Estimate
Benzinga
2026.11.10
12 Information Technology Stocks Moving In Tuesday's After-Market Session
Benzinga
2026.11.10
12 Energy Stocks Moving In Tuesday's After-Market Session
Benzinga
2026.11.10
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga
2026.11.10
12 Industrials Stocks Moving In Tuesday's After-Market Session
Benzinga
2026.11.10
Spectral AI Lowers FY2026 Sales Guidance from $18.500M to $13.000M vs $18.543M Est
Benzinga
2026.11.10
Marchex Appoints Travis Fairchild President, Effective Nov. 9
Benzinga
2026.11.10
Fed’s Bowman Says Would Need To See AI, Middle East Risks Abate Before Could Be Confident Inflation Will Come Down Next Year; I’m Shifting My Focus To Inflation; Open Lines Of Communication With Treasury Are Critically Important; Don't Think AI Will Rob...
Benzinga
2026.11.10
NanoXplore Sees Q2 Sales $31.000M-$32.000M
Benzinga
2026.11.10
Lumexa Imaging Holdings Raises FY2026 Adj EPS Guidance from $0.71-$0.77 to $0.86-$0.90 vs $0.77 Est; Affirms FY2026 Sales Guidance of $1.045B-$1.097B vs $1.067B Est
Benzinga
2026.11.10
If You Invested $100 In Micron Technology Stock 10 Years Ago, You Would Have This Much Today
Benzinga
2026.11.10
Beachbody Co Sees Q4 Sales $38.000M-$42.000M vs $47.431M Est
Benzinga
2026.11.10
The Beachbody Company, Inc. Class A Common Stock Q3 Adj. EPS $0.09 Beats $(0.18) Estimate, Sales $45.185M Miss $46.258M Estimate
Benzinga
2026.11.10
Gladstone Land Q3 FFO $0.37 Beats $0.07 Estimate, Sales $31.471M Beat $17.534M Estimate
Benzinga
2026.11.10
'OpenAI Revenue Jumps to $10B in Third Quarter'- The Information
Benzinga
2026.11.10
KORU Medical Systems Raises FY2026 Sales Guidance from $47.500M-$48.500M to $48.000M-$48.500M vs $48.030M Est
Benzinga
2026.11.10
NanoXplore Affirms FY2027 Sales Guidance of $130.000M-$140.000M vs $139.367M Est
Benzinga
2026.11.10
BrightView Hldgs Sees FY2027 Sales $2.535B-$2.720B vs $2.764B Est
Benzinga
2026.11.10
CC Capital, Motive Agree To Sell Wilshire To Marsh; Financial Terms Not Disclosed
Benzinga
1
...
100
101
102
103
104
105
...
712
>